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Abstract
Purpose Obesity and depression have both been shown to
be associated with reduced physical activity (PA). How-
ever, most studies have not applied objective measures to
determine PA in patients. Moreover, to our knowledge, no
studies are available comparing depressed and non-de-
pressed patients with regard to PA.
Methods We investigated PA in 47 patients with both
obesity and depression, 70 non-depressed patients with
obesity, and 71 non-depressed and non-obese healthy
control participants using the SenseWearTM Armband
(SWA) with walked steps per day and metabolic equiva-
lents (MET) as parameters for PA.
Results Depressed as well as non-depressed patients with
obesity showed a significantly reduced PA as reflected by
walked steps as well as reduced METs. Healthy controls
walked a mean of 11,586 ± 3731 (SD) steps per day,
whereas non-depressed patients with obesity accumulated
7283 ± 3547 and patients with both obesity and depression
recorded only 6177 ± 3291 steps per day. However, the
difference between depressed and non-depressed patients
with obesity did not reach statistical significance either in
terms of walked steps or with regard to METs.
Conclusions Obesity seems to be associated with a sub-
stantial reduction of PA and energy expenditure, whereas
the effect of an additional depressive disorder was com-
parably small. Even though depression did not have any
statistically significant effect on steps and METs per day in
this study with obese patients, it could be clinically rele-
vant for an individual patient.
Keywords Steps  Activity  Actigraphy  Depression 
Obesity
Introduction
Depression and obesity are two of today’s major public
health issues that cause a magnitude of disease burden,
functional disability and mortality [1–7]. According to the
World Health Organization (WHO), *350 million people
worldwide suffer from depression [6], and 600 million
people are obese [7].
Obesity is an excessive fat accumulation that may
impair health [7], and is defined by the WHO as having a
body mass index (BMI) C30 kg/m2 [7]. It has been
reported to increase the likelihood of various diseases,
particularly heart disease, type 2 diabetes, obstructive sleep
apnoea, certain types of cancer, and osteoarthritis [8]. It
most commonly develops on the basis of interactive fac-
tors: a combination of excessive food energy intake against
the background of the modern obesogenic food environ-
ment, the lack of physical activity (PA) in contemporary
daily life, and genetic susceptibility [8–10]. The modern
food environment is characterized by readily available
snacks, caloric beverages, foods with high palatability and
high energy density, large portion sizes, comparatively low
price, and ready availability [9]. Of the main causal factors,
C. Sander and P. Ueck contributed equally to this work.
& Hubertus Himmerich
hubertus.himmerich@kcl.ac.uk
1 Department of Psychiatry and Psychotherapy, University
Hospital Leipzig, Leipzig, Germany
2 Department of Psychological Medicine, King’s College
London, 103 Denmark Hill, London SE5 8AF, UK
3 Leipzig University Medical Center, IFB Adiposity Diseases,
Leipzig, Germany
123
Eat Weight Disord
DOI 10.1007/s40519-016-0347-8
caloric intake and PA remain best suited to therapeutic
influence.
Physical activity is inversely related to body weight and
fat mass as shown, for example, in the European
prospective investigation into cancer and nutrition (EPIC)
study [10] using data from more than 4,00,000 study par-
ticipants; for further review on studies regarding the rela-
tionship between PA, fat mass and obesity, see [11, 12].
Neuropeptides and cytokines seem to modify this associ-
ation as plasma levels of the neuropeptide orexin-A have
been shown to be lower in patients with obesity, but higher
in participants with obesity who are more physically active
[13], and levels of interleukin (IL-4), IL-10 and IL-13 have
been reported to be elevated in participants with low PA
[14].
Medical literature clearly demonstrates beneficial
effects of PA on several health outcomes, including its
role as a protective factor against cardiovascular disease
and all-cause mortality [15]. Regular PA has been shown
to reduce symptoms of anxiety and depression and to
increase both physical and psychological quality of life
[16, 17]. Worldwide, however, one out of every five
adults is considered physically inactive, which is defined
as being engaged in \20 min per day of vigorous-in-
tensity PA on at least 3 days per week or \30 min per
day of moderate PA on at least 5 days a week [18, 19].
The most objective measure to determine PA is actigra-
phy [20, 21] which makes a record of the activity level
of the body. These actigraphy devices use various tech-
nologies such as piezoelectric effects to measure accel-
eration along a movement axis [22]. Typically, the device
is worn for a specific period of time to continuously
record gross motor activity using an accellerometer.
Actigraphy has been in use since the 1980s to quantify
PA [23].
A reciprocal relationship between obesity and depres-
sion has been observed. Obesity has been reported to
increase the risk for depression [24–30] and, in turn,
depression has been shown to increase the risk for obesity
[31–38] in prospective studies. Typical symptoms of
depression include fatigue and loss of energy [39]. Indi-
viduals with such symptoms are more likely to engage in
lower levels of PA, which, in turn, facilitates the devel-
opment of obesity. Indeed, depressive symptoms have been
found to be associated with very little or even no PA
[40–42], and case control studies showed less PA in acutely
depressed patients compared to remitted patients or healthy
controls [43–47]. Moreover, scientific data suggest that PA
is a preventative measure against depressive symptoms in
patients with obesity [42]. This finding indicates that
research around obesity, depression and PA might be of
clinical relevance for patients with obesity to avoid the
development of depression as co-morbid with obesity.
However, we are not aware of any study that has
specifically investigated the level of PA in lean depressed
patients compared to lean healthy controls. Similarly, we
did not find any investigation examining the difference
between depressed and non-depressed patients with obe-
sity. It is yet unclear whether patients suffering from both
obesity and depression are less physically active than
patients with obesity but without depression. This question
bears a significant clinical impact, because if patients with
both obesity and depression are less physically active than
non-depressed individuals with obesity, it would put them
at an additional risk for sequelae of obesity. As depression
is a treatable disorder, this additional risk may be avoid-
able. Evaluation of the additional risk of low PA due to
depression for patients suffering from another disease is not
a novel research idea. The risk of low PA due to depression
has, for example, also been evaluated for patients suffering
from chronic obstructive pulmonary disease (COPD) [48]
and fibromyalgia [44]. There are some published studies
using actigraphy to determine differences in PA between
patients with and without depression [44] (for review see
[47]), and also between patients with and without obesity
[10, 11]. Yet again, to the knowledge of the authors, studies
comparing the actigraphy-measured activity of depressed
obese patients and non-depressed patients are not available.
If depressed patients with obesity were less physically
active than non-depressed patients with obesity, the group
of patients suffering from both obesity and depression
would be at a specifically high risk for health consequences
of inactivity as well as for reduced wellbeing and limited
quality of life. For the measurement of activity in the
present study, we used a SenseWearTM Armband (SWA)
which is an established actometric method [49–51] to
objectively measure PA.
Taken together, no studies are available comparing
patients with both depression and obesity and patients with
obesity but not depression with regard to objectively
measured PA. The present study first investigates whether
patients with obesity are less physically active than healthy
controls and, secondly, whether patients who are both
depressed and obese are less physically active than non-
depressed patients with obesity.
Methods
Participants
In total, we recruited 304 participants from the outpatient
clinic of the Integrated Research and Treatment Center for
Adiposity Diseases Leipzig (IFB), from the Department of
Psychiatry and Psychotherapy of the University Hospital
Leipzig and via announcements (intranet, internet, local
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newspapers). All participants were aged between 18 and
70 years.
For the present study, we selected from the pool of
available participants who had partaken in an actigraphy
recording and whose actigraphy data fulfilled certain
quality criteria (see below). According to their BMI and
their BDI2 total score, those participants (N = 188) were
classified as belonging to three groups: (a) N = 47 patients
with depression (BDI2 score[13 points) and obesity (BMI
C30); (b) N = 70 non-depressed (BDI2 score B13 points)
patients with obesity; and (c) N = 71 non-depressed and
non-obese (BMI\ 30) control participants.
Socio-demographic data are shown in Table 1. There
was no significant difference in gender ratio (v2 = 0.755,
p = 686) between the three groups. However, a one-way
ANOVA revealed a significant difference in mean age
[healthy controls: 34.3 (±12.0) years, non-depressed
patients with obesity: 43.3 (±13.2) years, patients with
obesity and depression: 43.6 (±12.5) years;
F(2,185) = 11.553, p\ .001], since the control group was
significantly (p\ .001) younger compared to the two
obese groups, who did not differ in mean age. Although not
statistically significant, the number of smokers was highest
in the obese-depressed group compared to the other two
groups yet, as mentioned, this difference did not reach
significance (v2 = 2.399, p = .301). For obvious reasons,
the three groups differed significantly concerning BMI
[healthy controls: 23.4 (±3.3), obese/non-depressed: 43.7
(±7.4), obese/depressed: 47.0 (±8.1); F = 258.094,
p\ .001] and BDI2-scores (F(2,185) = 182.655, p\ .001),
as the controls had lower BMI scores compared to the two
obese-groups (p\ .001), whereas the obese-depressed
groups scored higher in the BDI2 compared to the two non-
depressed groups (p\ .001).
Measures and procedure
For recruitment, potential participants were contacted via
phone and invited to participate in a telephone screening
interview, comprising socio-demographic data, screening
for somatic disorders and a checklist of the structured
clinical interview for DSM-IV [52]. Eligible participants
were then invited to the study center, where exclusion
criteria were assessed in more detail. Exclusion criteria
were acute or chronic infections, current medication with a
recognized major impact on the immune system, current
psychiatric medication, psychiatric and neurological dis-
orders apart from depression, and a history of head injury
with loss of consciousness exceeding 1 h. Assessments for
current and past history of physical and mental health
problems as well as current medication were performed
using standardized forms.
Study participants underwent a full physical examina-
tion by a study physician. Qualified healthcare profes-
sionals performed all examinations. Weight [kg] was
determined in underwear and without shoes using a digital
scale calibrated and standardized using a weight of known
mass. Height [cm] was recorded using a stadiometer with
participants standing on a flat surface at a right angle to the
vertical board of the stadiometer. BMI [kg/m2] was defined
as body weight [kg] divided by the square of height [m2].
After inclusion in the study, participants answered
questionnaires including the German version of the revised
Beck Depression Inventory second edition, (BDI2)
[53, 54]. The German version of the BDI2 demonstrated
good reliability and validity in clinical and nonclinical
samples for assessing self-rated severity of depression and
for assessing the course of depressed symptoms under
treatment [55]. We used the cutoff score of 13 in accor-
dance with Beck’s original manual for evaluation of the
BDI2 [55]. This cutoff was also applied in previous studies
using the German version of the BDI2, where depressed
inpatients showed a mean BDI2 score around 33, whereas
non-clinical samples exhibited a mean BDI2 score of\8
[54].
In a subgroup of the original sample, a 1-week actig-
raphy recording was performed, using the SenseWear Pro
3 actigraph (SWA; BodyMedia Inc.; Pittsburgh, Pennsyl-
vania). This device is attached to the upper right arm and
records 2-axis body acceleration, skin temperature, heat
Table 1 Sample characteristics
Healthy
controls
Non-depressed patients with
obesity
Patients with both obesity and
depression
N 71 70 47
Gender [f/m] 48/23 51/19 31/16 v2 = 0.755, p = .686
Age (mean ± SD) 34.32 ± 12.041 43.33 ± 13.225 43.62 ± 12.538 F = 11.553, p\ .001
Smoker [yes/no] 13/58 14/56 33/14 v2 = 2.399, p = .301
BMI (mean ± SD) 23.36 ± 3.299 43.73 ± 7.412 47.04 ± 8.098 F = 258.094, p\ .001
BDI2 score (mean ± SD) 4.27 ± 4.188 5.54 ± 3.929 21.89 ± 7.927 F = 182.655, p\ .001
BMI body mass index, BDI2 beck depression inventory, second edition
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flux and galvanic skin response. Furthermore, the device
detects periods in which it is not worn (off-arm periods).
Recordings were collected between the telephone screen-
ing and assessment day. Participants kept a sleep and
activity diary throughout the recording period. Actigraphic
data were analyzed using SenseWear Professional Soft-
ware Version 7 (BodyMedia Inc.) for estimation of number
of steps and METs per 1-min timeframe using validated
proprietary scoring algorithms included in the software.
A MET is a physiological measure expressing the energy
cost of PA.
Several studies have demonstrated that the SWA device
provides accurate estimates of energy expenditure during
rest and daily life activities, comparable to the gold stan-
dards of indirect calorimetry and doubly labeled water
[49–51, 56–59].
Score data were entered into a customized Excel-Tem-
plate for further data preparation. According to sleep
scoring from the software and sleep logs provided by the
participants, the wake phase (i.e., daytime) was determined
as between two consecutive night sleep intervals. For each
daytime interval, the variables’ steps (=sum of steps per
1 min-segment) and METs (=mean of all MET values per
1 min-segment) were calculated and afterwards averaged
to obtain mean values for the total week. Datasets were
included in the analysis if they contained analyzable data
for at least 5 daytime intervals, i.e., at least 3 week days
and both weekend days.
Results
Steps
The average amount of steps taken per day differed among
the three samples [healthy controls: 11,585.6 (Mean)
± 3730.68 (SD); obese/non-depressed: 7282.9 ± 3546.60;
obese/depressed: 6177.0 ± 3291.19; see also Fig. 1a].
Since there was a significant correlation between steps and
age in the total sample (steps: 8631.4 ± 4245.48; age:
40.0 ± 13.31 years; q = -0.265, p\ .001, we included
age as a covariate and performed an ANCOVA, which
revealed a significant main effect of group
(F(2,184) = 33.665; p\ .001: g
2 = 0.268) but not of age
(F(1,184) = 0.912; p = .341; g
2 = 0.005). Post hoc com-
parisons of the three groups proved that healthy controls
differed from obese/non-depressed (p\ .001) as well as
obese/depressed (p\ .001) participants, whereas the latter
two did not differ from each other (p = .103).
In the total sample, there was a significant negative
correlation between BMI and average amount of steps
(q = -0.605, p\ .001; see also Fig. 2a), which was only
seen in the obese/non-depressed subgroup (q = -0.450,
p\ .001), but not in healthy controls (q = -0.105,
p = .384) or the obese/depressed subgroup (q = -0.100;
p = .503).
METs
The three groups also had different average MET values
per day [healthy controls: 1.99 (Mean) ± 0.361 (SD);
obese/non-depressed: 1.20 ± 0.247; obese/depressed:
1.13 ± 0.228; see also Fig. 1b]. Again, there was a sig-
nificant correlation between age and METs in the total
sample (METs: 1.48 ± 0.494; age: 40.0 ± 13.31 years;
q = -0.308, p\ .001). Thus, age was again included as
covariate into the ANCOVA, which revealed a significant
main effect of group (F(2,184) = 152.627; p\ .001;
g2 = 0.624) but not of age (F(1,184) = 0.181; p = .671;
g2 = 0.001). Post hoc comparisons of the three groups
again resulted in significant differences between healthy
controls and obese/non-depressed (p\ .001) as well as
obese/depressed (p\ .001) participants, but no significant
differences were observed between the two obese groups
(p = .189).
There was a significant and strong negative correlation
between BMI and average MET values (q = -0.836,
p\ .001; see also Fig. 2a) in the total sample. A moderate
negative but significant association was also seen in the
obese/non-depressed subgroup (q = -0.587; p\ .001),
whereas only weak associations were seen in healthy
controls (q = -0.415, p\ .001) and the obese/depressed
subgroup (q = -0.363, p = .012).
Conclusions
In the present study, we found significantly less PA in
patients with obesity compared to healthy controls, which
aligns with previous studies finding lower levels of activity
in obese patients [10, 11]. According to our findings using
an SWA, healthy controls walked a mean of roughly
11,500 steps per day, patients with obesity but not
depression walked approximately 7000 and patients with
both obesity and depression walked about 6000 steps per
day. We also used METs as a measure of PA. Regarding
this physiological measure reflecting the energy cost of PA,
the lower level of PA associated with obesity was likewise
substantial, whereas an additional depressive symptoma-
tology was not associated with a further significantly lower
energy expenditure. Moreover, we found a significant
negative association between PA and the BMI as a con-
tinuous variable for the total group and the subgroup of
non-depressed patients with obesity.
Results of the previous studies vary considerably, as
they were performed in different countries, span different
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age groups and use different definitions of healthy weight
range in addition to varying instruments to measure the
steps walked per day or METs per day [60–63]. However,
independent of the cultural background and the age range,
they found differences between patients with obesity and
individuals with a healthy weight. Overall, their walked
steps data are similar to the range we found in our inves-
tigation [60–63].
For example, a French study regarding PA in adoles-
cents with obesity found that individuals with a healthy
weight walked about 10,000 steps per day, whereas patients
with obesity did about 9000 as measured by an SWA [60].
In this study, the METs were analyzed revealing a value of
1.8 for healthy weight and 1.3 for study participants with
obesity which is quite close to the MET values we obtained
(see Fig. 1b). A North American investigation using
Fig. 1 Amount of steps (part a left) and MET values (part b right) of healthy controls, non-depressed patients with obesity and patients with both
depression and obesity
Fig. 2 Relationship between BMI [kg/m2] and the amount of steps
walked during the wake phase (a left) and between the BMI and the
MET values during the wake phase (b right) of healthy controls, non-
depressed patients with obesity and patients with both depression and
obesity. The bold black line depicts the regression line for the total
group. The correlations were significant in the total group as well as
in the subgroup of patients with obesity but without depression
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pedometers found a mean of about 6000 steps per day in
healthy weight adults and about 4000 steps in participants
with obesity [61]. In a British study of older adults, normal
weight participants were significantly more active (with a
mean of more than 5000 steps per day) than patients with
obesity (mean about 3000 steps per day) [62]. In a Czech
study using the waist-hip-ratio (WHR) as an indicator for
excess weight and obesity, healthy study participants
walked about 8000 steps as measured by pedometry,
whereas participants with a risky WHR walked about 7000
steps [63].
As previous studies also showed reduced PA in
depressed patients [43–47], our aim was to investigate
whether participants with both obesity and depression
would be even less physically active than patients with
obesity but without depression. Although our data show a
trend in this direction, the results were not statistically
significant. These results demonstrate that obesity alone is
associated with an almost 50% reduction of walked steps
per day. Given an average stride length of about 73 cm,
this would mean that healthy controls in our study alleg-
edly walked about 8 km, whereas patients with obesity but
without depression would walk approximately 5 km per
day and patients with both obesity and depression would
walk about 4.5 km. When interpreting our data, one should
also consider that obesity and depression are closely related
[24–38] which means that it is difficult to disentangle and
isolate the effects of obesity and the effects of depression,
because there may be common causes underlying both
obesity and depression [64].
If we had found a significant difference in PA levels of
patients with obesity and depression in contrast to non-
depressed patients with obesity, this could have provided
robust support for recommending a depression screening
for every obese patient who needed an increase in PA. But
as there is only a trend in this direction, treatment against
depression does not seem to be of major relevance for
increasing PA in the subgroup of obese and depressed
patients. However, depression in itself is a disorder which
merits treatment [65], and which might have a huge impact
on the quality of life of obese patients [66]. Therefore, one
has to keep in mind that reduced PA is only one single
clinical feature of obese patients among others which might
be related to depression. Our study would have profited
from a second control group of patients with depression but
not obesity. This would have helped to separately evaluate
the influence of obesity and depression. Future studies
should consider such a methodological improvement.
There are several further shortcomings of our study, the
first of which is the sample size. One could argue that if we
had a larger study with more study participants, the effect
of depression in patients with obesity would most likely
have become significant. This expected increased
likelihood of significant results indicates that the sample
size used in additional studies on this topic should be lar-
ger. One should consider that in clinical terms, it may of
course be relevant for a specific obese patient to receive
treatment for depression, because the additional steps a
patient would undertake after a successful treatment of
depression might keep the patient under the threshold for
diabetes [67] or other adverse health consequences of
obesity.
As it is known from previous studies that PA declines
with age [68, 69], another shortcoming of our study was
that the group of healthy controls was younger than both
groups of obese patients. In addition, we found a significant
correlation between PA and age in our sample which
underlines how our data are representative and may,
therefore, be considered reliable. As reported in ‘‘Results’’,
we thus included age as a covariate when calculating
comparisons in terms of PA between the groups. However,
it would have been methodologically desirable to have
comparable age groups when comparing healthy and obese
participants.
Furthermore, patients taking medication which would
influence appetite and weight were not excluded from the
study, because we wished to minimize the loss of recruited
obese patients. Therefore, both groups of obese patients
include some patients taking antidiabetics such as met-
formin, which decreases appetite and can lead to weight
loss [70]. Thus, we have to bear in mind that this study is
based on a naturalistic sample of obese patients and healthy
controls.
A strength of this study, however, is the use of the SWA
to measure PA objectively. Although we can report a
negative association between obesity and PA, we are not
able to determine the direction of causality. PA may lead to
weight loss, but higher body weight may also lead to a
lower PA level. This converse causality may be the reason
why some interventions with increased PA do not have a
statistically significant effect on body weight [71].
However, even if a patient with obesity does not lose
weight by increasing their PA, the PA might help to mit-
igate negative consequences of obesity like the inflamma-
tory changes in the body or the development of depression
[14, 42]. For example, we could show that increased PA in
obese patients is associated with a decrease in cytokine
production, which most likely reflects a reduction in obe-
sity-induced inflammatory processes [14], and Dankel et al.
could show that PA might be a preventative measure
against depressive symptoms in patients with obesity [42].
Therefore, patients suffering from obesity should be
encouraged to be physically active.
Taken together, we investigated PA in healthy controls
and patients of a categorically obese BMI with or without
depression using an SWA by comparing METs spent and
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steps walked. We found that obesity was associated with a
substantial reduction of PA and energy expenditure,
whereas the effect of depressive symptoms was compara-
bly small.
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